Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep;8(3):166-70.

Intestinal parasitic infections among HIV seropositive and high risk group subjects for HIV infection in Nepal

Affiliations
  • PMID: 17203822

Intestinal parasitic infections among HIV seropositive and high risk group subjects for HIV infection in Nepal

Nabaraj A Adhikari et al. Nepal Med Coll J. 2006 Sep.

Abstract

Present study was carried out to find out the prevalence of intestinal parasites in HIV seropositive (HIV+) subjects and high risk group (HRG) for HIV infection in Nepal. A total 196 (HIV+: n = 112; Age: 16-52 years and HRG: n = 84; Age: 16-39 years) individuals were included. Stool specimens were examined by direct smear, formal-ether sedimentation, Sheather's sucrose floatation and Kinoyun modified Ziehl-Neelsen methods. Overall prevalence of intestinal parasites was 35.7% (70/196) (26.7% in HIV+ subjects and 47.6% in HRG subjects). Trichuris trichiura was the commonest parasite in HIV+ subjects (50.0%), whereas hookworm was most common among HRG subjects (56.8%). There was an association of parasitic infections with the gastrointestinal tract symptoms in both the study subjects. Tibeto-Burmans study subjects had marginally higher prevalence than Indo-Aryans study subjects (P > 0.05). Multiparasitic infections were relatively more common among HIV+ subjects (7.2%) in comparison to HRG subjects (4.8%). Similarly the protozoan infections were relatively higher in HIV+ subjects (4.5%) compared with HRG subjects (1.2%). The opportunistic protozoa Cryptosporidium parvum was detected only in 5.2% HIV+ subjects.

PubMed Disclaimer

MeSH terms